Signaling between leukemic and endothelial cells is bi-directional, as leukemia-mediated endothelial cell activation has been found to upregulate the cell adhesion molecule E-selectin, promoting AML cell quiescence and a chemo-resistant state [13]. The gene discussed is SELE; the disease is acute myeloid leukemia.